Real-world drug survival of ixekizumab for psoriasis

被引：9
|
作者：
Lee, Erica B. [1 ]
Pithadia, Deeti J. [2 ]
Reynolds, Kelly A. [3 ]
Reddy, Shivani P. [4 ]
Egeberg, Alexander [5 ]
Wu, Jashin J. [6 ]
机构：
[1] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA
[2] Augusta Univ, Med Coll Georgia, Augusta, GA USA
[3] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[4] Kaiser Permanente Los Angeles Med Ctr, Dept Dermatol, Los Angeles, CA USA
[5] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Hellerup, Denmark
[6] Dermatol Res & Educ Fdn, Irvine, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 01期
关键词：
PLAQUE PSORIASIS; NONRESPONDERS; EFFICACY; SAFETY; TRIALS;
D O I：
10.1016/j.jaad.2019.01.034
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：270 / 272
页数：4
相关论文
共 50 条
  • [41] Real-world comparison of monotherapy and concomitant medication use with biologic therapies for psoriasis: Ixekizumab versus guselkumab
    Blauvelt, Andrew
    Burge, Russel
    Charbonneau, Bridget
    Malatestinic, William
    Zhu, Baojin
    Wang, Fangyu
    Lockshin, Benjamin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB23 - AB23
  • [42] Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic Arthritis
    Elgaard, Cathrine Dawn Buttner
    Iversen, Lars
    Hjuler, Kasper Fjellhaugen
    DRUGS IN R&D, 2023, 23 (02) : 155 - 163
  • [43] Effectiveness End Points in Real-World Studies on Biological Therapies in Psoriasis: Systematic Review with Focus on Drug Survival
    Costanzo, Antonio
    Malara, Giovanna
    Pelucchi, Claudio
    Fatiga, Francesco
    Barbera, Giovanna
    Franchi, Andrea
    Galeone, Carlotta
    DERMATOLOGY, 2018, 234 (1-2) : 1 - 12
  • [44] Drug Survival Outcomes Associated with the Real-World Use of Ixekizumab, Secukinumab, Guselkumab, and Adalimumab for the Treatment of Plaque Psoriasis in China: A 52-Week Single-Center Retrospective Study
    Li, Ying
    Lu, Jia-Jing
    Zhong, Xiao-Yuan
    Yu, Ying-Yuan
    Yu, Ning
    Wang, Yu
    Yi, Xue-Mei
    Ding, Yang-Feng
    Shi, Yu-Ling
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 : 2245 - 2252
  • [45] Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic Arthritis
    Cathrine Dawn Büttner Elgaard
    Lars Iversen
    Kasper Fjellhaugen Hjuler
    Drugs in R&D, 2023, 23 : 155 - 163
  • [46] Drug survival of secukinumab in real-world plaque psoriasis patients: A 52-week, multicenter, retrospective study
    Georgakopoulos, Jorge R.
    Ighani, Arvin
    Phung, Michelle
    Yeung, Jensen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (05) : 1019 - 1020
  • [47] Drug survival of biologics in patients with psoriasis: real-world evidence for Greece during the period 2016-2020
    Lazaridou, Elizabeth
    Kourlaba, Georgia
    Ravanidis, Stylianos
    Gounelas, George
    Stefanou, Garyfallia
    Tsolakidis, Anastasios
    Mathioudakis, Konstantinos
    Apalla, Zoe
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (12) : 1573 - 1581
  • [48] Real-world evidence of Guselkumab for the treatment of moderate-to-severe psoriasis: Efficacy and drug survival analysis from the Australasian Psoriasis Registry
    Manuelpillai, Nicholas
    Parikh, Sumit
    Puig, Andrea
    Maranta, Debra
    Foley, Peter
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 9 - 9
  • [49] Drug survival 2.0-Real-world dosing of biologics for psoriasis
    Thein, David
    Roseno, Nana A. L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB44 - AB44
  • [50] Comparative Analysis of Ixekizumab Effectiveness with and Without Induction Therapy in Moderate-to-Severe Psoriasis: A Real-World Study
    Ruiz-Villaverde, Ricardo
    Ezomo-Gervilla, Pedro Jose
    Molina-Espinosa, Jose
    Galan-Gutierrez, Manuel
    Herrera-Acosta, Enrique
    Suarez-Perez, Jorge Alonso
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
12345